Patent US4377581A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4377581A Expired / Lapsed US ⏱️ 0.0 years remaining

Chloro- and alkoxy-substituted-2,4-diaminoquinazolines

Assignee: Pfizer Inc
•
Filing: 1981-04-10
•
Granted: 1983-03-22
•
Expires: 2001-04-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2,4-Diaminoquinazolines of the formula <IMAGE> (I) wherein Y1 is hydrogen or chloro, Y2 is OR, Y3 is hydrogen or OR such than when Y1 is hydrogen, Y3 is OR and when Y1 is chloro, Y3 is hydrogen or OR, and the pharmaceutically acceptable salts thereof; R represents an alkyl group having from one to three carbon atoms; taken separately, R1 and R2 are each hydrogen, alkyl having from one to five carbon atoms, cycloalkyl having from three to eight carbon atoms, alkenyl or alkynyl each having from three to five carbon atoms or hydroxy substituted alkyl having from two to five carbon atoms, when taken together with the nitrogen atom to which they are attached R1 and R2 form a substituted or unsubstituted heterocyclic group optionally containing an atom of oxygen, sulfur or a second atom of nitrogen as a ring member; their use as antihypertensive agents, pharmaceutical compositions containing them and intermediates for their production.

Inventors

  • 👤 Hans-Jurgen E. Hess
  • 👤 Jasjit S. Bindra
  • 👤 Praful K. Shah

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 14:31
CPC Classifications
C; C07; C07D; C07D413/00; C07D413/02; C07D413/04; C07C; C07C205/00; C07C205/44; C07C205/49; C07C205/57; C07C205/59; C07D211/00; C07D211/04; C07D211/06; C07D211/08; C07D211/18; C07D211/30; C07D211/32; C07D211/36; C07D211/40; C07D211/42; C07D211/44; C07D211/46; C07D239/00; C07D239/70; C07D239/72; C07D239/95; C07D239/96; C07D267/00; C07D267/02; C07D267/08; C07D267/10; C07D307/00; C07D307/02; C07D307/34; C07D307/56; C07D307/68; C07D319/00; C07D319/10; C07D319/14; C07D319/16; C07D319/20

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 731 words
A compound of the formula ##STR153## wherein Y 1 is chloro, Y 2 is OR and Y 3 is hydrogen or OR and the pharmaceutically acceptable acid addition salts thereof; R is alkyl having from one to three carbon atoms; R 1 and R 2 are the same or different and when taken separately are each a member selected from the group consisting of hydrogen, alkyl having from 1 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms; alkenyl having from 3 to 5 carbon atoms, alkynyl having from 3 to 5 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms and when taken together with the nitrogen atom to which they are attached R 1 and R 2 form ##STR154## where X 1 is a member selected from the group consisting of S(O) t , CHOR 6 , --(CH 2 ) p -- and CHR 7 , and X 2 is a member selected from the group consisting of X 1 , O, NR 3 , NCOR 4 and NCOOR 5 , where m is 2 or 3, n is 2 or 3, p is 1 to 3, t is 0, 1 or 2; R 3 is a member selected from the group consisting of hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl from 3 to 5 carbon atoms, alkynyl having from 3 to 5 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms, --(CH 2 ) q C 6 H 4 R 8 and --(CH 2 ) q C 10 H 6 R 8 , where q is 0 or 1; R 4 is a member selected from the group consisting of hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 3 to 5 carbon atoms, cycloalkyl and cycloalkylmethyl wherein said cycloalkyl has from 3 to 8 carbon atoms, ##STR155## R 10 , CH 2 R 10 and (CH 2 ) q C 6 H 4 R 8 where A is S or O, q is as defined above and R 10 is a member selected from the group consisting of ##STR156## where r is 1 or 2; R 5 is a member selected from the group consisting of alkyl having from 1 to 7 carbon atoms, alkenyl having 3 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms, CH 2 C 6 H 4 R 8 , CH 2 C 10 H 6 R 8 , CH 2 R 10 and CH 2 O-pyridyl; R 6 is a member selected from the group consisting of hydrogen, C 6 H 4 R 8 , --(CH 2 ) p Z R 15 , alkyl having from 1 to 6 carbon atoms and said alkyl substituted by a member selected from the group consisting of Cl, F, Br, OH, CH 3 O, SO 2 CH 3 and NHSO 2 CH 3 , where p and A are as previously defined and Z is a member selected from the group consisting of O, S, SO, SO 2 , and NR 16 ; R 7 is a member selected from the group consisting of alkyl having from one to six carbon atoms, hydroxyalkyl having from one to five carbon atoms, --(CH 2 ) q C 6 H 4 R 8 and COC 6 H 4 R 8 ; R 8 is a member selected from the group consisting of H, Cl, Br, F, CH 3 , CH 3 O, CF 3 , OH, SO 2 CH 3 and NHSO 2 CH 3 ; R 9 is a member selected from the group consisting of H, Cl, CH 3 , C 2 H 5 and phenyl; R 11 is hydrogen or methylthio and R 12 is a member selected from the group consisting of H, NH 2 alkyl having from one to four carbon atoms and NHCO 2 R 14 ; R 14 is alkyl having from one to four carbon atoms; R 15 is a member selected from the group consisting of alkyl having from one to four carbon atoms, C 6 H 4 R 8 and C 10 H 6 R 8 ; and R 16 is hydrogen or alkyl having from one to four carbon atoms.
Claim 2
Dependent Claim 731 words
A compound of the formula ##STR153## wherein Y 1 is chloro, Y 2 is OR and Y 3 is hydrogen or OR and the pharmaceutically acceptable acid addition salts thereof; R is alkyl having from one to three carbon atoms; R 1 and R 2 are the same or different and when taken separately are each a member selected from the group consisting of hydrogen, alkyl having from 1 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms; alkenyl having from 3 to 5 carbon atoms, alkynyl having from 3 to 5 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms and when taken together with the nitrogen atom to which they are attached R 1 and R 2 form ##STR154## where X 1 is a member selected from the group consisting of S(O) t , CHOR 6 , --(CH 2 ) p -- and CHR 7 , and X 2 is a member selected from the group consisting of X 1 , O, NR 3 , NCOR 4 and NCOOR 5 , where m is 2 or 3, n is 2 or 3, p is 1 to 3, t is 0, 1 or 2; R 3 is a member selected from the group consisting of hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl from 3 to 5 carbon atoms, alkynyl having from 3 to 5 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms, --(CH 2 ) q C 6 H 4 R 8 and --(CH 2 ) q C 10 H 6 R 8 , where q is 0 or 1; R 4 is a member selected from the group consisting of hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 3 to 5 carbon atoms, cycloalkyl and cycloalkylmethyl wherein said cycloalkyl has from 3 to 8 carbon atoms, ##STR155## R 10 , CH 2 R 10 and (CH 2 ) q C 6 H 4 R 8 where A is S or O, q is as defined above and R 10 is a member selected from the group consisting of ##STR156## where r is 1 or 2; R 5 is a member selected from the group consisting of alkyl having from 1 to 7 carbon atoms, alkenyl having 3 to 5 carbon atoms, cycloalkyl having from 3 to 8 carbon atoms, hydroxy substituted alkyl having from 2 to 5 carbon atoms, CH 2 C 6 H 4 R 8 , CH 2 C 10 H 6 R 8 , CH 2 R 10 and CH 2 O-pyridyl; R 6 is a member selected from the group consisting of hydrogen, C 6 H 4 R 8 , --(CH 2 ) p Z R 15 , alkyl having from 1 to 6 carbon atoms and said alkyl substituted by a member selected from the group consisting of Cl, F, Br, OH, CH 3 O, SO 2 CH 3 and NHSO 2 CH 3 , where p and A are as previously defined and Z is a member selected from the group consisting of O, S, SO, SO 2 , and NR 16 ; R 7 is a member selected from the group consisting of alkyl having from one to six carbon atoms, hydroxyalkyl having from one to five carbon atoms, --(CH 2 ) q C 6 H 4 R 8 and COC 6 H 4 R 8 ; R 8 is a member selected from the group consisting of H, Cl, Br, F, CH 3 , CH 3 O, CF 3 , OH, SO 2 CH 3 and NHSO 2 CH 3 ; R 9 is a member selected from the group consisting of H, Cl, CH 3 , C 2 H 5 and phenyl; R 11 is hydrogen or methylthio and R 12 is a member selected from the group consisting of H, NH 2 alkyl having from one to four carbon atoms and NHCO 2 R 14 ; R 14 is alkyl having from one to four carbon atoms; R 15 is a member selected from the group consisting of alkyl having from one to four carbon atoms, C 6 H 4 R 8 and C 10 H 6 R 8 ; and R 16 is hydrogen or alkyl having from one to four carbon atoms.
Claim 3
Dependent Claim 16 words
A compound according to claim 1 wherein Y 3 is hydrogen and Y 2 is methoxy.
Claim 4
Dependent Claim 15 words
A compound according to claim 1 wherein Y 2 and Y 3 are each methoxy.
Claim 5
Dependent Claim 25 words
A compound according to claim 1 wherein R 1 and R 2 taken together with the nitrogen atom to which they are attached form ##STR157##
Claim 6
Dependent Claim 37 words
A compound according to claim 4 wherein R 4 is a member of the group consisting of ##STR158## and cycloalkyl having from 3 to 8 carbon atoms and A, r and R 11 are as previously defined.
Claim 7
Dependent Claim 11 words
A compound according to claim 5 wherein R 4 is 2-furyl.
Claim 8
Dependent Claim 25 words
A compound according to claim 1 wherein R 1 and R 2 taken together with the nitrogen atom to which they are attached form ##STR159##
Claim 9
Dependent Claim 20 words
A compound according to claim 7 wherein R 5 is hydroxy substituted alkyl having from 2 to 5 carbon atoms.
Claim 10
Dependent Claim 11 words
A compound according to claim 8 wherein R 5 is 2-methyl-2-hydroxypropyl.
Claim 11
Dependent Claim 7 words
The compound according to claim 1: 2-[4-(2-furoyl)-1-piperazinyl]-4-amino-6-chloro-7-methoxyquinazoline.
Claim 12
Dependent Claim 7 words
The compound according to claim 1: 2-[4-(2-hydroxy-2-methylprop-1-yloxycarbonyl)piperazin-1-yl]-4-amino-6-chloro-7-methoxyquinazoline.
Claim 13
Dependent Claim 28 words
A pharmaceutical composition for oral or parenteral administration to a mammal comprising a pharmaceutically acceptable carrier and an antihypertensive effective amount of a compound according to claim 1.
Claim 14
Dependent Claim 11 words
The composition according to claim 12 wherein said compound is 2-[4-(2-furoyl)-1-piperazinyl]-4-amino-6-chloro-7-methoxyquinazoline.
Claim 15
Dependent Claim 11 words
The composition according to claim 12 wherein said compound is 2-[4-(2-hydroxy-2-methylprop-1-yloxycarbonyl)piperazin-1-yl]-4-amino-6-chloro-7-methoxyquinazoline.
Claim 16
Dependent Claim 30 words
A method for treating hypertension which comprises orally or parenterally administering to a mammal in need of such treatment an antihypertensive effective amount of a compound according to claim 1.
Claim 17
Dependent Claim 11 words
The method according to claim 15 wherein said compound is 2-[4-(2-furoyl)-1-piperazinyl]-4-amino-6-chloro-7-methoxyquinazoline.
Claim 18
Dependent Claim 11 words
The method according to claim 15 wherein said compound is 2-[4-(2-hydroxy-2-methylprop-1-yloxycarbonyl)piperazin-1-yl]-4-amino-6-chloro-7-methoxyquinazoline.

References Cited (Backward Citations)

US3511836A Cited
US3669968A Cited
US3920636A Cited
US4026984A Cited
US4001238A Cited
US4001237A Cited
US4060615A Cited
US4101548A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-03-21 1986-09-20 1987-03-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-03-21 1990-09-20 1991-03-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-03-21 1994-09-20 1995-03-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag